Riskpilot← Back to searchSign inGet full accessHASSINGEN APOTEK AS
ASActiveOrg 925159980Hassingveien 40, 1605 FredrikstadRetail sale of pharmaceutical products · NACE 4773Est. 202014 employees
Revenue 2025
NOK 34,2M
+7% vs 2024
EBITDA margin
4.1%
-31% vs 2024
Equity ratio
2.0%
Financial strength
Net profit 2025
NOK 1,1M
-32% vs 2024
| Revenue | NOK 34,2M | +7% |
| EBITDA | NOK 1,4M | -31% |
| Net profit | NOK 1,1M | -32% |
| Total assets | NOK 6,3M | -13% |
| Equity | NOK 128K | -21% |
| Employees | 14 | — |
Legal name
HASSINGEN APOTEK AS
Org number
925159980
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
5. juni 2020
Share capital
NOK 30 000
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Apotekvirksomhet og salg av andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på en annen måte gjøre seg interessert i andre foretak.
Address
Hassingveien 40, 1605 Fredrikstad
Phone
+4769700233
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 14 907 | 18 823 | 23 912 | 32 015 | 34 207 |
| Staff expenses | −2 466 | −3 141 | −3 708 | −4 568 | −5 312 |
| EBITDA | 1 160 | 862 | 1 499 | 2 043 | 1 420 |
| Depreciation & amort. | −163 | −167 | −146 | −80 | −90 |
| EBIT | 997 | 695 | 1 353 | 1 963 | 1 330 |
| Net financials | −129 | −95 | −10 | 46 | 39 |
| Profit before tax | 869 | 599 | 1 343 | 2 009 | 1 369 |
| Tax | 157 | 131 | 296 | 443 | 303 |
| Net profit | 712 | 469 | 1 047 | 1 565 | 1 066 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 283 | 5 510 | 9 362 | 7 193 | 6 277 |
| Equity | 581 | 1 049 | 597 | 162 | 128 |
| Long-term debt | 2 025 | 1 036 | 56 | 61 | 60 |
| Short-term debt | 2 678 | 3 425 | 8 709 | 6 970 | 6 089 |
| Total debt | 4 703 | 4 461 | 8 766 | 7 031 | 6 149 |
EBITDA margin
4.1%
This company
15.8%
Market median
-74% vs market
20212025
Equity ratio
2.0%
This company
38.2%
Market median
-95% vs market
20212025
Return on equity
831.2%
This company
18.4%
Market median
+4417% vs market
20212025
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
20212025
Asset turnover
5.45×
This company
1.12×
Market median
+387% vs market
20212025
Debt / equity
47.94×
This company
0.62×
Market median
-7632% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Former (2) | ||
| Board of Directors | 2020 – 2023 | |
| Board of Directors | 2023 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Junipatrullen Ab | Company | 45% | 45% | 2024 |
| Company | 30% | 30% | 2024 | |
| Company | 25% | 25% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HASSINGEN APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Petter Moi | Board of Directors | 0 companies |
| Axel Peter Larsen | Chairman | 0 companies |
| Atle Martin Haug | Board of Directors | 0 companies |
| Hanne Aasberg | Board of Directors | 0 companies |
| Ole-Jørgen Pettersen | Board of Directors | 0 companies |